Page last updated: 2024-10-28

halothane and Graves Disease

halothane has been researched along with Graves Disease in 2 studies

Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kotov, IA1
Bel'shov, VV1
Servin, FF1
Nivoche, Y1
Desmonts, JM1
Rice, SA1
Mazze, RI1

Other Studies

2 other studies available for halothane and Graves Disease

ArticleYear
[Peridural anesthesia in operations for toxic goiter].
    Vestnik khirurgii imeni I. I. Grekova, 1977, Volume: 118, Issue:2

    Topics: Adolescent; Adult; Aged; Anesthesia, Endotracheal; Anesthesia, Epidural; Blood Pressure; Cardiac Out

1977
Biotransformation of halothane and enflurane in patients with hyperthyroidism.
    Anesthesiology, 1986, Volume: 64, Issue:3

    Topics: Adenoma; Adult; Anesthesia, General; Biotransformation; Bromides; Enflurane; Female; Fluorides; Grav

1986